
The present invention discloses a novel 6-fluoro-1,4-dihydro-7- [4-(2-hydroxyiminoethyl)-1-piperazinyl] -4-oxoquinoline-3- carboxylic acid derivatives(formula I), with a process for their preparation, and with pharmaceutical compositions containing them as the active ingredient for the treatment of bacterial infections and/or renal cancer diseases.
Licensees sought.